Are you using technology to get the right patient for your study? Read this blog to understand the power of technology and how it can improve your clinical trial recruitment challenges…
How can patient-centricity ensure your planned study is feasible? The answer is simple: patient-centric studies are more feasible because they are attractive, convenient, engaging, and understanding of patient needs…
The volume of international studies is growing, with the market for global clinical trials expected to be worth $65.2 billion by 2025.1 Some of the key drivers of the increased globalization of clinical studies include the expanding R&D investments by drug developers in emerging health markets…
There is a growing interest in therapeutic advancements in genomics medicine, orphan drugs, and precision medicine. This interest has driven the need to generate robust clinical findings that can set a momentum for stakeholder acceptance of newly approved treatments. Yet many clinical trials continue struggle to generate quality trial results as they deal with clinical development inefficiencies and ballooning costs.
Patient recruitment costs vary between therapeutic areas, but consistent across diseases is the significant share of a trial budget required to recruit the appropriate participants. Yet in our recent ‘Innovation in Patient Recruitment’ survey, 41% of respondents with buying power had no budget specifically for recruiting participants for research.
Pharmaceutical companies of today are under increasing pressure to fully demonstrate the safety, effectiveness, and economic value of new medicines. The industry shift towards precision medicine and outcomes-based assessments also puts pressure on researchers to address the growing complexity of clinical study protocols. Failure to manage this complexity could compromise the integrity of your clinical studies, slow down the momentum of drug development, all leading to delay in approvals.
Patient-centricity is a critical component of a successful clinical trial, which can improve patient enrollment and retention. It helps overcome the many challenges faced by study teams by addressing the growing demands of an evolving patient population – who are actively engaged in their healthcare.
Clariness today announced it has acquired Viomedo, a leading online platform for clinical trials and provider of patient enrollment services.
Clariness congratulates Micah Stanbridge on completing his ride across America!! Micah, you did a great job raising awareness and funds for patients with blood cancer. Since starting his ride, 25 people have signed up to be stem cell donors. It took Micah 6 weeks to finish his 4,100 mile trek from the Pacific Ocean to
Micah Stanbridge has reached Virginia! He is just a few hundred miles shy of the East Coast. He should reach the end of his ride in about 3 days, weather permitting. Today was his first rainy day on his ride. He’s had excellent luck so far. He has been on the road for 39 days!
Subscribe to our monthly newsletter for pharma news, company insights and free downloads.